Standard Specialty PA and QL List October 2013

Similar documents
Specialty Drug Program RX Benefit Member Guide

PATIENT ASSISTANCE PROGRAMS

MEDICAL ASSISTANCE BULLETIN

Pain management for cancer patients Acute Ischemic Stroke. Hemophilia, Von willebrand disease & Bleeding disorders. Infectious Disease

STAT Bulletin. Drug Therapy Guideline Updates. May 11, 2012 Volume: 18 Issue: 12

encourages correct prescription drug use for a particular diagnosis, promotes the safe use of prescription drugs, and helps reduce drug costs.

Self-injectable, infused and oral specialty drugs 2014 Aetna Specialty CareRx SM Benefits Plan Drug List

2016 MDwise HIP Medical Services that Require Prior Authorization

2016 MDwise HIP Medical Services that Require Prior Authorization

Alameda Alliance for Health SPECIALTY PHARMACY PROGRAM FOR ALLIANCE MEDI-CAL AND GROUP CARE MEMBERS PROGRAM DESCRIPTION

Drugs Requiring Prior Authorization. Olysio. Subsys. Prolia. Tecfidera

Great-West s Drug Prior Authorization

REFERRAL/AUTHORIZATION GUIDELINES Commercial Plans

Special Authorization

Specialty Pharmacy Program Drug List

Medical School for Actuaries. June 12, Baltimore, Maryland

Humana 2015 Autorización previa

Prescription Drug Benefit Description

Provider Manual. This manual is to help you learn more about The Ohio State University s medical plans, administered by OSU Health Plan Inc.

CONNECTICARE, INC. & AFFILIATES

Fourth Quarter 2014 Provider Connection

N/A N/A N/A. Supporting statement of diagnosis from the N/A. physician and documented trial of 1 generic. formulary alternative

Specialty drug trend

COVERAGE MANAGEMENT PROGRAMS

UMASTER PREFERRED DRUG LIST (DRUG FORMULARY) Effective July 1, 2015 RA05/15.654

NDC HCPCS HCPCS Description NDC Description Effective Date End Date X-Over Only

Local Coverage Article: Self-Administered Drug Exclusion List (A51866)

January 1, 2016 At A Glance. CSEA Civil Service Employees Association

SPECIAL AUTHORIZATION GUIDELINES

This information is also available in large print. Call TTY users should call toll-free

MEDICAL BENEFIT BOOKLET

Review of the List of High-Cost Medicines used by the Dominican Republic s Protected Diseases Program and Planning of Purchases for 2015

comparison of access and reimbursement environments A report benchmarking Australia s access to new medicines Edition 1

INJECTABLES/MEDICATIONS ADMINISTERED UNDER THE MEDICAL BENEFIT Authorization Required List Not Related to Bleeding and Clotting Disorders

Specialty Pharmacy: Understanding the Market and Solution. Your Goals. Presented by Chris Brown November 2009

Meridian Health Plan Drugs Covered under the Medical Benefit* Updated 09/2015 PA Required

ClearScript Prior Authorization Drug List

Medical Prior Authorization List For prescription drug requirements, see plan formularies.

Drugs That Require Prior Authorization (PA) Before Being Approved for Coverage PRIOR AUTHORIZATION MEDICATIONS

Medicare Part D Drugs that Require Prior-Authorization Effective 12/01/2015

Effective: July 28, Arizona Prior Authorization Requirements Health Net Access, Inc.

Participating Provider Precertification List

2013 Prior Authorization (PA) Criteria

Immune Modulating Drugs Prior Authorization Request Form

ICORE Healthcare: Injectable Drug Utilization Management Program Overview for EmblemHealth Providers. May 1, 2012

22 Medicare Provider Manual

Multiple Sclerosis Step Therapy and Quantity Limit Criteria

ACTEMRA. Cigna Medicare Rx (PDP) 2014 Cigna Medicare Rx Secure Plan (PDP) Formulary. Products Affected Actemra. Prior Authorization Criteria

HealthPartners, Inc Medicare Part D Formulary ID 13142, Version 22 Prior Authorization Criteria. Last Updated: 11/01/2013

Medi-Cal Expansion, Mental Health Services and Changes to Medi-Cal Prior Authorization Requirements

ACS CAN Examination of Cancer Drug Coverage and Transparency in the Health Insurance Marketplaces

Specialty Pharmacy. Business Plan. July 8, RUSH University Medical Center

Covered California s 2016 Formularies

INPATIENT SERVICES Commercial Medicare. Notification required only, as soon as possible, but no later than 24 hours

Non-urgent Pre-service requests---within 3 business days of receipt of request. Urgent Pre-service requests---within 72 hours of receipt of request

Items Covered Benefit for Preferred Vendor Contact Information. Medicaid ONLY Integra Phone

The Newcastle upon Tyne Hospitals NHS Foundation Trust. Handling, Segregation and Disposal of Cytostatic and Cytotoxic Waste

Study Support Materials Cover Sheet

Medication Policy Manual. Topic: Plegridy, peginterferon beta-1a Date of Origin: December 12, 2014

Brand Generic J-Code Covered Uses Required Medical Information and Criteria

Prior Authorization Criteria 2014

Commercial Medicines Unit

Rheumatic Diseases, Psoriasis, and Crohn s Disease

Drug Formulary Update, July 2013

Medication Policy Manual. Topic: Betaseron, Extavia, interferon beta-1b Date of Origin: June 18, 2004

April 2014 Medicine use and shifting costs of healthcare

Filtration Guidelines for the Administration of Intravenous Medications UK Pharmacy Services Revised 8/2010

Information About Medicines for Multiple Sclerosis

Commonwealth of Massachusetts Executive Office of Health and Human Services Office of Medicaid

Effective Date: 6/3/14

Cytokine and CAM Antagonists

Prior authorization. (a) Any medical service may be placed by the

Prior Authorization FID VER.7 UPDATED 8/2015

ACNE PRODUCTS. Affected Drugs: Epiduo Retin-A Tretinoin. Covered Uses: All FDA-approved indications not otherwise excluded from Part D

New Oral Chemotherapeutic Agents: Part B vs. Part D Implications

January 1, Participating Agencies

Pharmacotherapy of Autoimmune Disorders

PULMONARY ARTERIAL HYPERTENSION AGENTS

Multiple Sclerosis Center of Nebraska

ACTEMRA. Step Therapy Criteria HEALTH CHOICE EXCHANGE 2016 Effective Date: 01/01/2016. PRODUCT(s) AFFECTED ACTEMRA

Information about medicines for multiple sclerosis

Inventory of Access and Prices of Orphan Drugs across Europe:

ACTEMRA. Products Affected. Actemra

2016 Prior Authorization Requirements

All FDA-approved indications not otherwise excluded from Part D. Plus patients already started on tocilizumab for a Covered Use.

Committee Approval Date: December 12, 2014 Next Review Date: December 2015

Alla chme nl A EFFECTIVE 07/01/2014 BUREAU FOR MEDICAL SERVICES WEST VIRGINIA MEDICAID PREFERRED DRUG LIST WITH PRIOR AUTHORIZATION CRITERIA

2015 PA CRITERIA. UCare for Seniors is an HMO-POS plan with a Medicare contract. Enrollment in UCare for Seniors depends on contract renewal.

Development of the market of special care drugs

Medication Policy Manual. Topic: Aubagio, teriflunomide Date of Origin: November 9, 2012

How To Treat Rheumatoid Arthritis

Cytokine and CAM Antagonists

Building A Fully Integrated Biotech Company:

Drug List Limitations, Exclusions and Preauthorization Criteria

NOVARTIS SERVICE REQUEST FORM FOR PATIENT SUPPORT

Transcription:

Anti-infectives Antiretrovirals, Hepatitis B Antiretrovirals, HIV Cardiology Antilipemic Pulmonary Arterial Hypertension Central Nervous System Depressant Neurotoxins Parkinson's Endocrinology & Metabolism Gonadotropins Growth Hormones and Related Therapy BARACLUDE (entecavir) HEPSERA (adefovir) TYZEKA (telbivudine ) FUZEON (enfuvirtide) SELZENTRY (maraviroc) 60 vials or 1 kit/30 days TRUVADA (emtricitabine/tenofovir) JUXTAPID (lomitapide) 20 mg JUXTAPID (lomitapide) 5 mg, 10 mg 3 tabs/day KYNAMRO (mipomersen) 4 syringes/28 days ADCIRCA (tadalafil) FLOLAN (epoprostenol) LETAIRIS (ambrisentan) REMODULIN (treprostinil) REVATIO (sildenafil) 3 tabs or vials/day TRACLEER (bosentan) TYVASO (treprostinil) 1 ampule/day VELETRI (epoprostenol) VENTAVIS (iloprost) 9 ampules/day XYREM (sodium oxybate) BOTOX (onabotulinumtoxina) 3 bottles (540 ml)/30 days DYSPORT (abobotulinumtoxina) MYOBLOC (rimabotulinumtoxinb) XEOMIN (incobotulinumtoxina) APOKYN (apomorphine) ELIGARD (leuprolide) 22.5 mg (3-month) ELIGARD (leuprolide) 30 mg (4-month) 1 injection/112 days ELIGARD (leuprolide) 45 mg (6-month) 1 injection/168 days ELIGARD (leuprolide) 7.5 mg (1-month) FIRMAGON (degarelix) 120 mg FIRMAGON (degarelix) 80 mg 2 vials/year 1 vial/28 days LUPRON (leuprolide) 1 mg/0.2 ml No QL for this strength LUPRON DEPOT (leuprolide) 11.25 mg & 22.5 mg (3-month) LUPRON DEPOT (leuprolide) 3.75 mg & 7.5 mg (1-month) LUPRON DEPOT (leuprolide) 30 mg (4-month) 1 injection/112 days LUPRON DEPOT (leuprolide) 45 mg (6-month) LUPRON DEPOT-PED (leuprolide) 11.25 mg & 30 mg (3-month) 1 injection/168 days LUPRON DEPOT-PED (leuprolide) 7.5 mg, 11.25 mg, & 15 mg SUPPRELIN LA (histrelin acetate) 1 kit/365 days TRELSTAR (triptorelin) 22.5 mg (6-month) TRELSTAR DEPOT (triptorelin) 3.75 mg (1-month) 1 injection/168 days TRELSTAR LA (triptorelin) 11.25 mg (3-month) VANTAS (histrelin) ZOLADEX (goserelin) 10.8 mg 1 implant/year ZOLADEX (goserelin) 3.6 mg EGRIFTA (tesamorelin) 1 mg 2 vials (1 mg each)/day EGRIFTA (tesamorelin) 2 mg 1 vial (2 mg each)/day GENOTROPIN (somatropin) Updated 10/10/2013 Page 1 of 6

Osteoporosis Somatostatins Enzyme-Related Alpha-1 proteinase inhibitor Cystine-depleting Agents Enzyme Replacement Enzyme, Gout Phenylketonuria Treatment Agents Gastroenterology Endocrinology & Metabolism HUMATROPE (somatropin) INCRELEX (mecasermin) NORDITROPIN (somatropin) NUTROPIN (somatropin) NUTROPIN AQ (somatropin) OMNITROPE (somatropin) SAIZEN (somatropin) SEROSTIM (somatropin) SOMAVERT (pegvisomant) TEV-TROPIN (somatropin) ZORBTIVE (somatropin) H.P. ACTHAR (corticotropin) PROLIA (denosumab) 2 syringes/year RECLAST (zoledronic acid) SANDOSTATIN (octreotide) SANDOSTATIN LAR (octreotide) SIGNIFOR (pasireotide) 2 ampules/day SOMATULINE DEPOT (lanreotide) ARALAST (alpha-1 proteinase inhibitor) GLASSIA (alpha-1 proteinase inhibitor) PROLASTIN (alpha-1 proteinase inhibitor) ZEMAIRA (alpha-1 proteinase inhibitor) CYSTARAN (cysteamine) 4 bottles/28 days PROCYSBI (cysteamine bitartrate) ADAGEN (pegademase) ALDURAZYME (laronidase) CARBAGLU (carglumic acid) CEREZYME (imiglucerase) ELAPRASE (idursulfase) ELELYSO (taliglucerase) FABRAZYME (agalsidase beta) LUMIZYME (alglucosidase alfa) MYOZYME (alglucosidase alfa) NAGLAZYME (galsulfase) RAVICTI (glycerol phenylbutyrate) VPRIV (velaglucerase) ZAVESCA (miglustat) KRYSTEXXA (pegloticase) KUVAN (sapropterin) Short Bowel Syndrome GATTEX (teduglutide) Immunology Anti-inflammatory Biologic Agents ACTEMRA (tocilizumab) CIMZIA (certolizumab) ENBREL (etanercept) HUMIRA (adalimumab) KINERET (anakinra) ORENCIA (abatacept) REMICADE (infliximab) SIMPONI (golimumab) Updated 10/10/2013 Page 2 of 6

Hematopoietic Agents Hepatitis C Agents Immune Globulins Interleukins Multiple Sclerosis Immunology SIMPONI ARIA (golimumab) STELARA (ustekinumab) XELJANZ (tofacitinib) ARANESP (darbepoetin alfa) EPOGEN (epoetin alfa) LEUKINE (sargramostim) MOZOBIL (plerixafor) 8 vials (9.6 ml) per transplant NEULASTA (pegfilgrastim) NEUMEGA (oprelvekin) NEUPOGEN (filgrastim) NPLATE (romiplostim) OMONTYS (peginesatide) PROCRIT (epoetin alfa) PROMACTA (eltrombopag) 12. 5mg, 25 mg 3 tabs/day PROMACTA (eltrombopag) 50 mg, 75 mg SOLIRIS (eculizumab) INCIVEK (telaprevir) INFERGEN (interferon alfacon-1) PEGASYS (peginterferon alfa-2a) PEG-INTRON (peginterferon alfa-2b) VICTRELIS (boceprevir) BIVIGAM (immune globulin) CARIMUNE (immune globulin) CYTOGAM (cytomegalovirus immune globulin) FLEBOGAMMA (immune globulin) FLEBOGAMMA DIF (immune globulin) GAMASTAN (immune globulin) GAMMAGARD (immune globulin) GAMMAKED (immune globulin) GAMMAPLEX (immune globulin) GAMUNEX (immune globulin) GAMUNEX-C (immune globulin) HIZENTRA (immune globulin) OCTAGAM (immune globulin) PRIVIGEN (immune globulin) VARIZIG (varicella-zoster immune globulin) ARCALYST (rilonacept) ILARIS (canakinumab) BENLYSTA (belimumab) AMPYRA (dalfampridine) AUBAGIO (teriflunomide) AVONEX (interferon beta-1a) 1 kit (4 syringes)/28 days BETASERON (interferon beta-1b) 1 package/28 days COPAXONE (glatiramer) 1 kit/30 days EXTAVIA (interferon beta-1b) 1 package/28 days GILENYA (fingolimod) 1 cap/day NOVANTRONE (mitoxantrone) REBIF (interferon beta-1a) 12 syringes/28 days TECFIDERA (dimethyl fumarate) 120 mg 14 caps/year TECFIDERA (dimethyl fumarate) 240 mg 2 caps/day TECFIDERA (dimethyl fumarate) Starter Pack 2 starter packs/year TYSABRI (natalizumab) 1 injection /28 days Updated 10/10/2013 Page 3 of 6

Immunology Transplant NULOJIX (belatacept) ZORTRESS (everolimus) Collagenase XIAFLEX (collagenase clostridium histolyticum) Diagnostic Movement Disorder Agents THYROGEN (thyrotropin alfa) XENAZINE (tetrabenazine) 6 vials/year Toxicology EXJADE (deferasirox) FERRIPROX (deferiprone) Viscosupplements EUFLEXXA (sodium hyaluronate) GEL-ONE (sodium hyaluronate) HYALGAN (sodium hyaluronate) ORTHOVISC (sodium hyaluronate) SUPARTZ (sodium hyaluronate) SYNVISC (sodium hyaluronate) SYNVISC-ONE (sodium hyaluronate) Obstetrics & Gynecology Hormone Replacement MAKENA (hydroxyprogesterone caproate) Oncology Alkylating Agents Antiandrogen Antimicrotubular Interferons Kinase and Molecular Target Inhibitors MYLERAN (busulfan) TEMODAR (temozolomide) XTANDI (enzalutamide ) ZYTIGA (abiraterone) HALAVEN (eribulin) JEVTANA (cabazitaxel) INTRON A (interferon alfa-2b) SYLATRON (peginterferon alfa-2b) AFINITOR (everolimus) AFINITOR DISPERZ (everolimus) BOSULIF (bosutinib) CAPRELSA (vandetanib) 100 mg CAPRELSA (vandetanib) 300 mg No QL for this strength COMETRIQ (carbozantinib) ERIVEDGE (vismodegib) GILOTRIF (afatinib) GLEEVEC (imatinib) ICLUSIG (ponatinib) 15 mg ICLUSIG (ponatinib) 45 mg No QL for this strength INLYTA (axitinib) JAKAFI (ruxolitinib) KYPROLIS (carfilzomib) MEKINIST (trametinib) NEXAVAR (sorafenib) PERJETA (pertuzumab) SPRYCEL (dasatinib) STIVARGA (regorafenib) SUTENT (sunitinib) TAFINLAR (dabrafenib) TARCEVA (erlotinib) TASIGNA (nilotinib) TYKERB (lapatinib) VELCADE (bortezomib) Updated 10/10/2013 Page 4 of 6

Monoclonal Antibody Thalidomide-related Agents Respiratory Asthma/COPD Cystic fibrosis Respiratory Syncytial Virus Agents Oncology VOTRIENT (pazopanib) XALKORI (crizotinib) ZALTRAP (ziv-aflibercept) ZELBORAF (vemurafenib) DACOGEN (decitabine) ERWINAZE (asparaginase) ISTODAX (romidepsin) SYNRIBO (omacetaxine) TARGRETIN (bexarotene) VIDAZA (azacitidine) XELODA (capecitabine) ZOLINZA (vorinostat) ZOMETA (zoledronic acid) ADCETRIS (brentuximab) HERCEPTIN (trastuzumab) KADCYLA (ado-trastuzumab emtansine) RITUXAN (rituximab) XGEVA (denosumab) QL Varies* YERVOY (ipilimumab) POMALYST (pomalidomide) REVLIMID (lenalidomide) THALOMID (thalidomide) XOLAIR (omalizumab) BETHKIS (tobramycin) CAYSTON (aztreonam) KALYDECO (ivacaftor) PULMOZYME (dornase alfa) TOBI (tobramycin) TOBI PODHALER (tobramycin) 1 package (224 tabs)/56 days SYNAGIS (palivizumab) Updated 10/10/2013 Page 5 of 6

Standard QL Programs Therapeutic Category Drug Name Dispensing Limit Anti-infectives Antiretrovirals, HIV ATRIPLA (efavirenz/emtricitabine/tenofovir) COMPLERA (emtricitabine/rilpivirine/tenofovir) STRIBILD (elvitegravir/cobicistat/emtricitabine/tenofovir) TRIZIVIR (abacavir/lamivudine/zidovudine) Cardiology Anticoagulants, LMWH ARIXTRA (fondaparinux) 35 days supply/180 days FRAGMIN (dalteparin) LOVENOX (enoxaparin) 35 days supply/180 days 35 days supply/180 days Endocrinology & Metabolism Osteoporosis Vasopressin Antagonist FORTEO (teriparatide) SAMSCA (tolvaptan) 1 syringe/28 days 30 days/60 days Obstetrics & Gynecology Fertility Agents BRAVELLE (urofollitropin) CETROTIDE (cetrorelix) 0.25 mg 60 vials/30 days 14 boxes/30 days CETROTIDE (cetrorelix) 3 mg 1 box/30 days Chorionic gonadotropin (chorionic gonadotropin) 20 ml/30 days FOLLISTIM AQ (follitropin beta) 30 vials or 20 cartridges/30 days Ganirelix acetate (ganirelix) 20 syringes (0.5 ml)/30 days GONAL-F (follitropin alfa) 3 vials/30 days GONAL-F RFF (follitropin alfa) OVIDREL (choriogonadotropin) 60 pens or vials/30 days 2 syringes (1 ml)/30 days REPRONEX (menotropins) 60 vials/30 days Hormone Replacement CRINONE (progesterone) 8% 54 applicators/30 days PLEASE NOTE: This drug list is subject to periodic updates and may not be all inclusive. Drugs affected include both brand and generic where applicable and includes all dosage formulations unless otherwise specifically notated. If a new drug is approved and falls into one of the targeted PA categories, the new drug may automatically be added to this list. Quantity limits may also apply. *Quantity limits are built into the PA criteria approval and varies based on indication and/or other clinical factors. Updated 10/10/2013 Page 6 of 6